| Year |
Citation |
Score |
| 2012 |
Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, Beck BH, Kesterson RA, Desmond RA, Frost AR, Hurst DR, Welch DR. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical & Experimental Metastasis. 29: 315-25. PMID 22241150 DOI: 10.1007/S10585-012-9452-X |
0.498 |
|
| 2007 |
Gestl SA, Leonard TL, Biddle JL, Debies MT, Gunther EJ. Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands. Molecular and Cellular Biology. 27: 195-207. PMID 17060457 DOI: 10.1128/MCB.01525-06 |
0.683 |
|
| 2006 |
Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Letters. 235: 260-5. PMID 15978719 DOI: 10.1016/J.Canlet.2005.04.032 |
0.425 |
|
| 2004 |
Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, Mercer R, Jewell J, Mastro AM, ... ... Debies MT, et al. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clinical & Experimental Metastasis. 21: 119-28. PMID 15168729 DOI: 10.1023/B:Clin.0000024763.69809.64 |
0.357 |
|
| 2001 |
Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 6: 441-51. PMID 12013533 DOI: 10.1023/A:1014739131690 |
0.418 |
|
| 2001 |
Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J, Welch DR. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Research. 61: 8866-72. PMID 11751410 |
0.526 |
|
| Show low-probability matches. |